Fenoldopam Infusion for Renal Protection in High-Risk Cardiac Surgery Patients: A Randomized Clinical Study

Andrea A. Cogliati, Raffaella Vellutini, Antonia Nardini, Sali Urovi, Mazen Hamdan, Giovanni Landoni, Paolo Guelfi

Research output: Contribution to journalArticlepeer-review


Objective: The purpose of this study was to evaluate the renoprotective effects of fenoldopam in patients at high risk of postoperative acute kidney injury undergoing elective cardiac surgery requiring cardiopulmonary bypass. Design: A double-blind randomized clinical trial. Setting: Hospital. Participants: One hundred ninety-three patients. Interventions: Patients undergoing cardiac surgery were randomly assigned to receive a continuous infusion of fenoldopam, 0.1 μg/kg/min (95 patients), or placebo (98 patients) for 24 hours. Patients were included if at least 1 of the following risk factors was present: preoperative serum creatinine ≥1.5 mg/dL, age >70 years, diabetes mellitus, or prior cardiac surgery. Serum creatinine and urinary output were measured at baseline (T1), 24 hours (T2), and 48 hours after surgery (T3). Acute kidney injury was defined as a postoperative serum creatinine level of ≥2 mg/dL with an increase in serum creatinine level of 0.7 mg/dL or greater from preoperative to maximum postoperative values. Measurements and Main Results: Acute kidney injury developed in 12 of 95 (12.6%) patients receiving fenoldopam and in 27 of 98 (27.6%) patients receiving placebo (p = 0.02), whereas renal replacement therapy was started in 0 of 95 and 8 of 98 (8.2%) patients, respectively (p = 0.004). Serum creatinine was similar at baseline (1.8 ± 0.4 mg/dL v 1.9 ± 0.3 mg/dL) in the fenoldopam and placebo groups but differed significantly (p <0.001 and p <0.001) 24 hours (1.6 ± 0.2 mg/dL v 2.5 ± 0.6 mg/dL) and 48 hours (1.5 ± 0.3 mg/dL v 2.8 ± 0.4 mg/dL) after the operation. Conclusions: A 24-hour infusion of 0.1 μg/kg/min of fenoldopam prevented acute kidney injury in a high-risk population undergoing cardiac surgery.

Original languageEnglish
Pages (from-to)847-850
Number of pages4
JournalJournal of Cardiothoracic and Vascular Anesthesia
Issue number6
Publication statusPublished - Dec 2007


  • acute renal failure
  • cardiac anesthesia
  • cardiac surgery
  • cardiopulmonary bypass
  • fenoldopam

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Fenoldopam Infusion for Renal Protection in High-Risk Cardiac Surgery Patients: A Randomized Clinical Study'. Together they form a unique fingerprint.

Cite this